Tick saliva is a potent inhibitor of endothelial cell proliferation and angiogenesis

Ivo M. B. Francischetti; Thomas N. Mather; José M. C. Ribeiro

doi:10.1160/TH04-09-0566

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 94(01): 167-174
DOI: 10.1160/TH04-09-0566

Endothelium and Vascular Development

Schattauer GmbH

Tick saliva is a potent inhibitor of endothelial cell proliferation and angiogenesis

Ivo M. B. Francischetti

¹Vector Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA

,

Thomas N. Mather

²Center for Vector-Borne Disease, University of Rhode Island, Kingston, Rhode Island, USA

,

José M. C. Ribeiro

¹Vector Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA

› Author Affiliations

Abstract

Summary

We report for the first time that saliva of the hard tick and Lyme disease vector,Ixodes scapularis,is a potent inhibitor of angiogenesis. Saliva (≤ 1:500 dilutions) or salivary gland (0.1–0.5 pairs/assay) dose-dependently inhibits microvascular endothelial cell (MVEC) proliferation. Inhibition was also detected with the saliva of the cattle tick Boophilus microplus but not with the salivary gland of Anopheles gambiae, An. stephensi, Lutzomyia longipalpis, Phlebotomus papatasi, Aedes aegypti, Culex quinquefasciatus, and Cimex lectularius. Inhibition of MVEC proliferation by I. scapularis saliva was accompanied by a change in cell shape (shrinkage of the cytoplasm with loss of cell-cell interactions) and apoptosis which was estimated by expression of phosphatidylserine using the Apopercentage dye, and by a typical pattern of chromatin margination, condensation, and fragmentation as revealed by nuclear staining with Hoechst 33258.The effect of saliva appears to be mediated by endothelial cell α5β1 integrin, because monoclonal antibodies against this but not αvβ3, αvβ5, α9β1, or α2β1 integrins remarkably block its effect. In addition, SDS/PAGE shows that saliva specifically degrades purified α5β1 but not αvβ5 or αvβ3 integrins. Incubation of saliva with EDTA and 1,10-phenanthroline, but not phenylmethylsulfonyl fluoride (PMSF), inhibits saliva-dependent degradation of purified α5β1 integrin, suggesting that a metalloprotease is responsible for the activity. Finally, saliva at ≤ 1:1,000 dilutions blocks sprouting formation from chick embryo aorta implanted in Matrigel, an in vitro model of angiogenesis. These findings introduce the concept that tick saliva is a negative modulator of angiogenesis-dependent wound healing and tissue repair, therefore allowing ticks to feed for days. Inhibition of angiogenesis was hitherto an unidentified biologic property of the saliva of any blood-sucking arthropod studied so far. Its presence in tick saliva may be regarded as an additional source of angiogenesis inhibitors with potential applications for the study of both vector and vascular biology.

Keywords

Tick saliva - angiogenesis - wound healing - Ixodes scapularis - integrin

Full Text

References

References
1 Folkman J, Shing T. Angiogenesis. J Biol Chem 1992; 167: 10931-4.
2 Risau W. Mechanism of angiogenesis. Nature 1997; 386: 671-4.
3 Li J, Zhang Y. P, Kirsner RS. Angiogenesis and wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech 2003; 60: 107-14.
4 Neal MS. Angiogenesis: is it the key to controlling the healing process?. J Wound Care 2001; 10: 281-7.
5 Ribeiro JM, Francischetti IM. Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives. Annu Rev Entomol 2003; 48: 73-88.
6 Ribeiro JM, Makoul GT, Levine J. et al. Antihemostatic, antiinflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes dammini . J Exp Med 1985; 161: 332-44.
7 Francischetti IM, Valenzuela JG, Andersen JF. et al. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex. Blood 2002; 99: 3602-12.
8 Tatchell RJ. A modified method for obtaining tick oral secretion. J Parasitol 1967; 53: 1106-7.
9 Zhang JC, Claffey C, Sakthivel R. et al. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J 2000; 14: 2589-600.
10 Mosnier LO, Griffin JH. Inhibition of staurosporine- induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Biochem J 2003; 373: 65-70.
11 Guo Y L, Wang S, Colman RW. Kininostatin, an angiogenic inhibitor, inhibits proliferation and induces apoptosis of human endothelial cells. Arterioscler Thromb Vasc Biol 2001; 21: 1427-33.
12 Malinda KM, Nomizu M, Chung M. et al. Identification of laminin α1 and β1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. FASEB J 1999; 13: 53-62.
13 Ponce ML, Nomizu M, Kleinman HK. An angiogenic laminin site and its antagonist bind through the α(v)β3 and α5β1 integrins. FASEB J 2001; 15: 1389-97.
14 Ribeiro JM, Zeidner NS, Ledin K. et al. How much pilocarpine contaminates pilocarpine-induced tick saliva?. Med Vet Entomol 2004; 18: 20-4.
15 Lee Y, Schacter E. Oxidative stress inhibits apoptosis in human lymphoma cells. J Biol Chem 1999; 274: 19792-8.
16 Stupack DG, Cheresh DA. Apoptotic cues from the extracellular matrix: regulators of angiogenesis. Oncogene 2003; 22: 9022-9.
17 You WK, Seo HJ, Chung KH. et al. A novel metalloprotease from Gloydius halys venom induces endothelial cell apoptosis through its protease and disintegrinlike domains. J Biochem 2003; 134: 739-49.
18 Francischetti IM, Mather TN, Ribeiro JM. Penthalaris, a novel recombinant five Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis . Thromb Haemost 2004; 91: 886-98.
19 Narasimhan S, Koski RA, Beaulieu B. et al. A novel family of anticoagulants from the saliva of Ixodes scapularis . Insect Mol Biol 2002; 11: 641-50.
20 Valenzuela JG, Charlab R, Mather TN. et al. Purification, cloning, and expression of a novel salivary anticomplement protein from the tick, Ixodes scapularis . J Biol Chem 2000; 275: 18717-23.
21 Montgomery RR, Lusitani D, De Boisfleury Chevance A. et al. Tick saliva reduces adherence and area of human neutrophils. Infect Immun 2004; 72: 2989-94.
22 Valenzuela JG, Francischetti IM, Pham VM. et al. Exploring the sialome of the tick Ixodes scapularis . J Exp Biol 2002; 18: 2843-64.
23 Francischetti IM, Mather TN, Riberio JM. et al. Cloning of a salivary gland metalloprotease and characterization of gelatinase and fibrin(ogen)lytic activities in the saliva of the Lyme disease tick vector Ixodes scapularis . Biochem Biophys Res Commun 2003; 305: 869-75.
24 Bjarnason JB, Fox JW. Snake venom metalloendopeptidases: reprolysins. Methods Enzymol 1995; 248: 345-68.
25 Brassard DL, Maxwell E, Malkowski M. et al. Integrin alpha(v)beta(3)-mediated activation of apoptosis. Exp Cell Res 1999; 251: 33-45.
26 Cominetti MR, Ribeiro JU, Fox JW. et al. BaG, a new dimeric metalloproteinase/disintegrin from the Bothrops alternatus snake venom that interacts with α5β1 integrin. Arch Biochem Biophys 2003; 416: 171-9.
27 Francischetti IM, My-Pham V, Harrison J. et al. Bitis gabonica (Gaboon viper) snake venom gland: toward a catalog for the full-length transcripts (cDNA) and proteins. Gene 2004; 337: 55-69.
28 Wu WB, Huang TF. Activation of MMP2, cleavage of matrix proteins, and adherens junctions during a snake venom metalloproteinase-induced endothelial cell apoptosis. Exp Cell Res 2003; 288: 143-57.
29 Zhang Z, Vuori K, Reed JC. et al. The α5β1 integrin supports survival of cells on fibronectin and upregulates Bcl2 expression. Proc Natl Acad Sci USA 1995; 92: 6161-5.
30 Takagi J, Strokovich K, Springer TA. et al. Structure of integrin α5β1 in complex with fibronectin. EMBO J 2003; 22: 4607-15.
31 Kim S, Bell K, Mousa SA. et al. Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin. Am J Pathol 2000; 156: 1345-62.
32 Pickering JG, Chow LH, Li S. et al. α5β1 integrin expression and luminal edge fibronectin matrix assembly by smooth muscle cells after arterial injury. Am J Pathol 2000; 156: 453-65.
33 Ingber DE. Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc Natl Acad Sci USA 1990; 87: 3579-83.
34 Molossi S, Elices M, Arrhenius T. et al. Lymphocyte transendothelial migration toward smooth muscle cells in interleukin-1β stimulated cocultures is related to fibronectin interactions with α4β1 and α5β1 integrins. J Cell Physiol 1995; 164: 620-33.
35 Zamir E, Katz M, Posen Y. et al. Dynamics and segregation of cell matrix adhesions in cultured fibroblasts. Nat Cell Biol 2000; 2: 191-6.
36 Tarui T, Andronicos N, Czekay RP. et al. Critical role of integrin α5β1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling. J Biol Chem 2003; 278: 298-6372.
37 Kloss CU, Werner A, Klein MA. et al. Integrin family of cell adhesion molecules in the injured brain: regulation and cellular localization in the normal and regenerating mouse facial motor nucleus. Comp Neurol 1999; 411: 162-78.
38 Feng X, Clark RA, Galanakis D. et al. Fibrin and collagen differentially regulate human dermal microvascular endothelial cell integrins: stabilization of αvβ3 mRNA by fibrin 1. J Invest Dermatol 1999; 113: 913-9.
39 Clark RAF, Della Pelle P, Manseua E. et al. Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J Invest Dermatol 1982; 79: 269-76.
40 Engbring JA, Kleinman HK. The basement membrane matrix in malignancy. J Pathol 2003; 200: 465-70.
41 Fernandez PM, Patierno SR, Rickles FR. Tissue factor and fibrin in tumor angiogenesis. Sem Thromb. Hemost 2004; 30: 31-44.
42 Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J. Invest. Dermatol. Symp. Proc. 2000; 5: 40-66.
43 Calvete JJ, Jurgens M, Marcinkiewicz C. et al. Disulphide bond pattern and molecular modeling of the dimeric disintegrin EMF10, a potent and selective integrin α5β1 antagonist from Eristocophis macmahoni venom. Biochem J 2000; 345: 573-81.
44 Hembrough TA, Ruiz JF, Swerdlow BM. et al. Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity. Blood 2004; 103: 3374-80.
45 Pike SE, Yao L, Setsuda J. et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 1999; 94: 2461-8.
46 Gillespie RD, Mbow ML, Titus RG. The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol 2000; 22: 319-31.
47 Schoeler GB, Wikel SK. Modulation of host immunity by haematophagous arthropods. Ann. Trop. Med. Parasitol 2001; 95: 75571.
48 Coleman JL, Gebbia JA, Piesman J. et al. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 1997; 89: 1111-9.
49 Zeidner NS, Schneider BC, Nuncio MS. et al. Coinoculation of borrelia spp. with tick salivary gland lysate enhances spirochete load in mice and is tick species-specific. J Parasitol 2002; 88: 1276-8.
50 Clark RA. In Goldsmith L. A.. (ed.) Physiology, biochemistry and molecular biology of the skin, 2nd ed.. I Oxford University Press; New York, NY: 1999: 577.